India Patent Disputes Heat Up For Big Pharma
This article was originally published in The Pink Sheet Daily
Executive Summary
Patient advocacy groups organize to appose applications they say impede access.
You may also be interested in...
Indian Court Hands Novartis Setback In Gleevec Patent Case
Novartis says decision will have innovation, intellectual property repercussions for other pharma firms operating in India.
Amgen And India’s Jubilant In Drug Discovery Partnership
Collaboration continues trend of Indian CROs involved early in the discovery process.
Dr. Reddy’s Sees Profit Drop As Pricing Pressure Hits Generics Industry
Revenues rose 25 percent, however, driven by North American markets.